Margaret L. Brandeau - Publications

Affiliations: 
Stanford University, Palo Alto, CA 
Area:
Industrial Engineering

73 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zhong H, Arjmand IK, Brandeau ML, Bendavid E. Health outcomes and cost-effectiveness of treating depression in people with HIV in Sub-Saharan Africa: a model-based analysis. Aids Care. 1-7. PMID 31986900 DOI: 10.1080/09540121.2020.1719966  0.414
2020 Barrow GJ, Fairley M, Brandeau ML. Optimizing interventions across the HIV care continuum: A case study using process improvement analysis Operations Research For Health Care. 25: 100258. DOI: 10.1016/J.Orhc.2020.100258  0.37
2019 Weyant C, Brandeau ML, Basu S. Personalizing Medical Treatment Decisions: Integrating Meta-Analytic Treatment Comparisons with Patient-Specific Risks and Preferences. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X19884927. PMID 31707910 DOI: 10.1177/0272989X19884927  0.303
2019 Claypool AL, Brandeau ML, Goldhaber-Fiebert JD. Quantifying Positive Health Externalities of Disease Control Interventions: Modeling Chikungunya and Dengue. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X19880554. PMID 31642362 DOI: 10.1177/0272989X19880554  0.322
2019 Barrow GJ, Brandeau ML. A modified HIV continuum of care: A six-year evaluation of a viral load cascade at a hospital-based clinic in Kingston, Jamaica. International Journal of Std & Aids. 956462419839514. PMID 31072281 DOI: 10.1177/0956462419839514  0.351
2018 Negoescu DM, Bimpikis K, Brandeau ML, Iancu DA. Dynamic Learning of Patient Response Types: An Application to Treating Chronic Diseases. Management Science. 64: 3469-3970. PMID 30344343 DOI: 10.1287/Mnsc.2017.2793  0.311
2018 Fu R, Owens DK, Brandeau ML. Cost-effectiveness of alternative strategies for provision of HIV pre-exposure prophylaxis for people who inject drugs. Aids (London, England). PMID 29334549 DOI: 10.1097/Qad.0000000000001747  0.45
2017 Bernard CL, Brandeau ML. Structural Sensitivity in HIV Modeling: A Case Study of Vaccination. Infectious Disease Modelling. 2: 399-411. PMID 29532039 DOI: 10.1016/J.Idm.2017.08.002  0.391
2017 Choi SE, Brandeau ML, Bendavid E. Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa. Malaria Journal. 16: 403. PMID 28985732 DOI: 10.1186/S12936-017-2047-X  0.397
2017 Suen SC, Brandeau ML, Goldhaber-Fiebert JD. Optimal timing of drug sensitivity testing for patients on first-line tuberculosis treatment. Health Care Management Science. PMID 28861650 DOI: 10.1007/S10729-017-9416-4  0.337
2017 Bernard CL, Owens DK, Goldhaber-Fiebert JD, Brandeau ML. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis. Plos Medicine. 14: e1002312. PMID 28542184 DOI: 10.1371/Journal.Pmed.1002312  0.46
2016 Bernard CL, Brandeau ML, Humphreys K, Bendavid E, Holodniy M, Weyant C, Owens DK, Goldhaber-Fiebert JD. Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States. Annals of Internal Medicine. PMID 27110953 DOI: 10.7326/M15-2634  0.441
2016 Fu R, Gutfraind A, Brandeau ML. Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections. Mathematical Biosciences. 273: 102-13. PMID 26775738 DOI: 10.1016/J.Mbs.2016.01.003  0.349
2016 Juusola JL, Brandeau ML. HIV Treatment and Prevention: A Simple Model to Determine Optimal Investment. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 36: 391-409. PMID 26369347 DOI: 10.1177/0272989X15598528  0.432
2014 Long EF, Mandalia R, Mandalia S, Alistar SS, Beck EJ, Brandeau ML. Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom. Plos One. 9: e95735. PMID 24763373 DOI: 10.1371/Journal.Pone.0095735  0.747
2014 Alistar SS, Owens DK, Brandeau ML. Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics. Plos One. 9: e86584. PMID 24489747 DOI: 10.1371/Journal.Pone.0086584  0.438
2014 Alistar SS, Long EF, Brandeau ML, Beck EJ. HIV epidemic control-a model for optimal allocation of prevention and treatment resources. Health Care Management Science. 17: 162-81. PMID 23793895 DOI: 10.1007/S10729-013-9240-4  0.753
2013 Hutton DW, Brandeau ML. Too much of a good thing? When to stop catch-up vaccination. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 33: 920-36. PMID 23858015 DOI: 10.1177/0272989X13493142  0.592
2013 Alistar SS, Brandeau ML, Beck EJ. REACH: A practical HIV resource allocation tool for decision makers International Series in Operations Research and Management Science. 190: 201-223. DOI: 10.1007/978-1-4614-6507-2_10  0.339
2012 Cipriano LE, Zaric GS, Holodniy M, Bendavid E, Owens DK, Brandeau ML. Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users. Plos One. 7: e45176. PMID 23028828 DOI: 10.1371/Journal.Pone.0045176  0.648
2012 Negoescu DM, Owens DK, Brandeau ML, Bendavid E. Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 1392-9. PMID 22942203 DOI: 10.1093/Cid/Cis731  0.322
2012 Juusola JL, Brandeau ML, Owens DK, Bendavid E. The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Annals of Internal Medicine. 156: 541-50. PMID 22508731 DOI: 10.7326/0003-4819-156-8-201204170-00001  0.439
2012 Alistar SS, Brandeau ML. Decision making for HIV prevention and treatment scale up: bridging the gap between theory and practice. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 32: 105-17. PMID 21191118 DOI: 10.1177/0272989X10391808  0.407
2012 Juusola JL, Brandeau ML, Owens DK, Bendavid E. The Cost-Effectiveness of Preexposure Prophylaxis for HIV Prevention in Men Who Have Sex with Men in the United States Annals of Internal Medicine. 156: 541. DOI: 10.1059/0003-4819-156-8-201204170-00001  0.435
2011 Enns EA, Brandeau ML, Igeme TK, Bendavid E. Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention International Journal of Std and Aids. 22: 558-567. PMID 21998175 DOI: 10.1258/Ijsa.2011.010322  0.473
2011 Hutton DW, Brandeau ML, So SK. Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions. Interfaces. 41: 289-300. PMID 21760650 DOI: 10.1287/Inte.1100.0511  0.607
2011 Juusola JL, Brandeau ML, Long EF, Owens DK, Bendavid E. The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. Aids (London, England). 25: 1779-87. PMID 21716076 DOI: 10.1097/Qad.0B013E328349F067  0.739
2011 Alistar SS, Owens DK, Brandeau ML. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine. Plos Medicine. 8: e1000423. PMID 21390264 DOI: 10.1371/Journal.Pmed.1000423  0.459
2011 Enns EA, Brandeau ML. Inferring model parameters in network-based disease simulation. Health Care Management Science. 14: 174-88. PMID 21373984 DOI: 10.1007/S10729-011-9150-2  0.331
2011 McCoy JH, Brandeau ML. Efficient stockpiling and shipping policies for humanitarian relief: UNHCR's inventory challenge Or Spectrum. 33: 673-698. DOI: 10.1007/S00291-011-0237-4  0.318
2010 Long EF, Brandeau ML, Owens DK. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Annals of Internal Medicine. 153: 778-89. PMID 21173412 DOI: 10.7326/0003-4819-153-12-201012210-00004  0.746
2010 Bendavid E, Brandeau ML, Wood R, Owens DK. Comparative effectiveness of HIV testing and treatment in highly endemic regions. Archives of Internal Medicine. 170: 1347-54. PMID 20696960 DOI: 10.1001/Archinternmed.2010.249  0.382
2010 Duriseti RS, Brandeau ML. Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms. Annals of Emergency Medicine. 56: 321-332.e10. PMID 20605261 DOI: 10.1016/J.Annemergmed.2010.03.029  0.74
2010 Armbruster B, Brandeau ML. Cost-effective control of chronic viral diseases: finding the optimal level of screening and contact tracing. Mathematical Biosciences. 224: 35-42. PMID 20043926 DOI: 10.1016/J.Mbs.2009.12.006  0.408
2010 Hutton DW, So SK, Brandeau ML. Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology (Baltimore, Md.). 51: 405-14. PMID 19839061 DOI: 10.1002/Hep.23310  0.6
2009 Brandeau ML, Zaric GS. Optimal investment in HIV prevention programs: more is not always better. Health Care Management Science. 12: 27-37. PMID 19938440 DOI: 10.1007/S10729-008-9074-7  0.648
2009 Long EF, Brandeau ML, Owens DK. Potential population health outcomes and expenditures of HIV vaccination strategies in the United States. Vaccine. 27: 5402-10. PMID 19591796 DOI: 10.1016/J.Vaccine.2009.06.063  0.723
2009 Tole SP, Sanders GD, Bayoumi AM, Galvin CM, Vinichenko TN, Brandeau ML, Owens DK. Cost-effectiveness of voluntary HIV screening in Russia. International Journal of Std & Aids. 20: 46-51. PMID 19103893 DOI: 10.1258/Ijsa.2008.008128  0.461
2008 Long EF, Vaidya NK, Brandeau ML. Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection Dynamics. Operations Research. 56: 1366-1381. PMID 19412348 DOI: 10.1287/Opre.1080.0571  0.722
2008 Brandeau ML, Zaric GS, Freiesleben J, Edwards FL, Bravata DM. An ounce of prevention is worth a pound of cure: improving communication to reduce mortality during bioterrorism responses. American Journal of Disaster Medicine. 3: 65-78. PMID 18522248 DOI: 10.5055/Ajdm.2008.0010  0.543
2008 Zaric GS, Bayoumi AM, Brandeau ML, Owens DK. The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 28: 359-76. PMID 18349433 DOI: 10.1177/0272989X07312714  0.638
2008 Zaric GS, Bravata DM, Cleophas Holty JE, McDonald KM, Owens DK, Brandeau ML. Modeling the logistics of response to anthrax bioterrorism. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 28: 332-50. PMID 18349432 DOI: 10.1177/0272989X07312721  0.554
2007 Brandeau ML, Hutton DW, Owens DK, Bravata DM. Planning the bioterrorism response supply chain: learn and live. American Journal of Disaster Medicine. 2: 231-47. PMID 18491839 DOI: 10.5055/Ajdm.2007.0032  0.56
2007 Armbruster B, Brandeau ML. Contact tracing to control infectious disease: when enough is enough. Health Care Management Science. 10: 341-55. PMID 18074967 DOI: 10.1007/S10729-007-9027-6  0.353
2007 Hutton DW, Tan D, So SK, Brandeau ML. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Annals of Internal Medicine. 147: 460-9. PMID 17909207 DOI: 10.7326/0003-4819-147-7-200710020-00004  0.588
2007 Armbruster B, Brandeau ML. Optimal mix of screening and contact tracing for endemic diseases. Mathematical Biosciences. 209: 386-402. PMID 17428503 DOI: 10.1016/J.Mbs.2007.02.007  0.351
2007 Zaric GS, Brandeau ML. A little planning goes a long way: multilevel allocation of HIV prevention resources. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 27: 71-81. PMID 17237455 DOI: 10.1177/0272989X06297395  0.645
2006 Long EF, Brandeau ML, Galvin CM, Vinichenko T, Tole SP, Schwartz A, Sanders GD, Owens DK. Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia. Aids (London, England). 20: 2207-15. PMID 17086061 DOI: 10.1097/Qad.0B013E328010C7D0  0.743
2006 Bravata DM, Zaric GS, Holty JE, Brandeau ML, Wilhelm ER, McDonald KM, Owens DK. Reducing mortality from anthrax bioterrorism: strategies for stockpiling and dispensing medical and pharmaceutical supplies. Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science. 4: 244-62. PMID 16999586 DOI: 10.1089/Bsp.2006.4.244  0.588
2006 Duriseti RS, Shachter RD, Brandeau ML. Value of quantitative D-dimer assays in identifying pulmonary embolism: implications from a sequential decision model. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 13: 755-66. PMID 16723725 DOI: 10.1197/J.Aem.2006.02.011  0.736
2005 Brandeau ML, Zaric GS, de Angelis V. Improved allocation of HIV prevention resources: using information about prevention program production functions. Health Care Management Science. 8: 19-28. PMID 15782509 DOI: 10.1007/S10729-005-5213-6  0.673
2004 Bravata DM, McDonald KM, Owens DK, Wilhelm ER, Brandeau ML, Zaric GS, Holty JE, Liu H, Sundaram V. Regionalization of bioterrorism preparedness and response. Evidence Report/Technology Assessment (Summary). 1-7. PMID 15133889  0.473
2003 Brandeau ML, Zaric GS, Richter A. Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis. Journal of Health Economics. 22: 575-98. PMID 12842316 DOI: 10.1016/S0167-6296(03)00043-2  0.769
2003 Zaric G, Bayoumi A, Brandeau M, Owens D. PIN40: THE COST EFFECTIVENESS OF IMPROVED ADHERENCE TO ANTIRETROVIRAL TREATMENT Value in Health. 6: 266. DOI: 10.1016/S1098-3015(10)64017-X  0.633
2002 Zaric GS, Brandeau ML. Dynamic resource allocation for epidemic control in multiple populations. Ima Journal of Mathematics Applied in Medicine and Biology. 19: 235-55. PMID 12828363 DOI: 10.1093/Imammb/19.4.235  0.591
2002 Grossman TA, Brandeau ML. Optimal pricing for service facilities with self-optimizing customers European Journal of Operational Research. 141: 39-57. DOI: 10.1016/S0377-2217(01)00233-8  0.353
2001 Barnett PG, Zaric GS, Brandeau ML. The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States. Addiction (Abingdon, England). 96: 1267-78. PMID 11672491 DOI: 10.1046/J.1360-0443.2001.96912676.X  0.649
2001 Zaric GS, Brandeau ML. Optimal investment in a portfolio of HIV prevention programs. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 21: 391-408. PMID 11575489 DOI: 10.1177/0272989X0102100506  0.65
2001 Rauner MS, Brandeau ML. AIDS policy modeling for the 21st century: an overview of key issues. Health Care Management Science. 4: 165-80. PMID 11519843 DOI: 10.1023/A:1011418614557  0.345
2001 Zaric GS, Brandeau ML. Resource allocation for epidemic control over short time horizons. Mathematical Biosciences. 171: 33-58. PMID 11325383 DOI: 10.1016/S0025-5564(01)00050-5  0.589
2000 Zaric GS, Bayoumi AM, Brandeau ML, Owens DK. The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States. Journal of Acquired Immune Deficiency Syndromes (1999). 25: 403-16. PMID 11141240 DOI: 10.1097/00042560-200012150-00004  0.658
2000 Zaric GS, Barnett PG, Brandeau ML. HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health. 90: 1100-11. PMID 10897189 DOI: 10.2105/Ajph.90.7.1100  0.687
2000 Thonemann UW, Brandeau ML. Optimal commonality in component design Operations Research. 48: 1-19. DOI: 10.1287/Opre.48.1.1.12445  0.319
2000 Zaric GS, Brandeau ML, Barnett PG. Methadone maintenance and HIV prevention: a cost-effectiveness analysis Management Science. 46: 1013-1031. DOI: 10.1287/Mnsc.46.8.1013.12025  0.687
1999 Richter A, Brandeau ML, Owens DK. An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non- users Medical Decision Making. 19: 167-179. PMID 10231079 DOI: 10.1177/0272989X9901900207  0.461
1998 Owens DK, Brandeau ML, Sox CH. Effect of relapse to high-risk behavior on the costs and benefits of a program to screen women for human immunodeficiency virus Interfaces. 28: 52-74. DOI: 10.1287/Inte.28.3.52  0.381
1998 Kahn JG, Brandeau ML, Dunn-Mortimer J. OR Modeling and AIDS Policy: From Theory to Practice Interfaces. 28: 3-22. DOI: 10.1287/Inte.28.3.3  0.459
1998 Zaric GS, Bayoumi AM, Brandeau ML, Owens DK. The Effects of Protease Inhibitors on the Spread of HIV and the Development of Drug-Resistant HIV Strains: A Simulation Study Simulation. 71: 262-275.  0.59
1993 Brandeau ML, Owens DK, Sox CH, Wachter RM. Screening Women of Childbearing Age for Human Immunodeficiency Virus: A Model-Based Policy Analysis Management Science. 39: 72-92. DOI: 10.1287/Mnsc.39.1.72  0.383
1992 Brandeau ML, Owens DK, Sox CH, Wachter RM. Screening Women of Childbearing Age for Human Immunodeficiency Virus: A Cost-benefit Analysis Archives of Internal Medicine. 152: 2229-2237. PMID 1444682 DOI: 10.1001/Archinte.1992.00400230047008  0.436
1991 Wachter RM, Cooke M, Brandeau ML, Owens DK. HIV Testing of Pregnant Women and Newborns Jama: the Journal of the American Medical Association. 265: 1525. PMID 1999895 DOI: 10.1001/Jama.1991.03460120039015  0.364
1991 Brandeau ML, Lee HL, Owens DK, Sox CH, Wachter RM. A Policy Model of Human Immunodeficiency Virus Screening and Intervention Interfaces. 21: 5-25. DOI: 10.1287/Inte.21.3.5  0.42
1987 Brandeau ML, Eddy DM. The Workup of the Asymptomatic Patient with a Positive Fecal Occult Blood Test Medical Decision Making. 7: 32-46. PMID 3100902 DOI: 10.1177/0272989X8700700108  0.303
Show low-probability matches.